|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 329 for Pbsn

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.144s

Categories

Category: Publication
« show all
Type Details Score
Publication
16820097 | J:114903
First Author: Kelavkar UP
Year: 2006
Journal: Neoplasia
Title: Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
Volume: 8
Issue: 6
Pages: 510-22
•
•
•
•
•
Publication
23755247 | J:206639
First Author: Xing C
Year: 2013
Journal: PLoS One
Title: Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells.
Volume: 8
Issue: 6
Pages: e65538
•
•
•
•
•
Publication
23428429 | J:198151
First Author: Nguyen AH
Year: 2013
Journal: Hum Mol Genet
Title: Gata3 antagonizes cancer progression in Pten-deficient prostates.
Volume: 22
Issue: 12
Pages: 2400-10
•
•
•
•
•
Publication
23727861 | J:203214
First Author: Wang G
Year: 2013
Journal: Nat Genet
Title: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
Volume: 45
Issue: 7
Pages: 739-746
•
•
•
•
•
Publication
23727860 | J:203215
First Author: Lunardi A
Year: 2013
Journal: Nat Genet
Title: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Volume: 45
Issue: 7
Pages: 747-55
•
•
•
•
•
Publication
34496233 | J:320671
First Author: Grbesa I
Year: 2021
Journal: Cell Rep
Title: Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.
Volume: 36
Issue: 10
Pages: 109625
•
•
•
•
•
Publication
24866151 | J:217845
First Author: González-Billalabeitia E
Year: 2014
Journal: Cancer Discov
Title: Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
Volume: 4
Issue: 8
Pages: 896-904
•
•
•
•
•
Publication
23845440 | J:199223
First Author: Karantanos T
Year: 2013
Journal: Cancer Cell
Title: GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer.
Volume: 24
Issue: 1
Pages: 11-3
•
•
•
•
•
Publication
33284790 | J:300165
First Author: Bousset L
Year: 2020
Journal: PLoS Biol
Title: Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.
Volume: 18
Issue: 12
Pages: e3000948
•
•
•
•
•
Publication
16079851 | J:100683
First Author: Chen Z
Year: 2005
Journal: Nature
Title: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Volume: 436
Issue: 7051
Pages: 725-30
•
•
•
•
•
Publication
29202479 | J:258828
First Author: Shoag J
Year: 2018
Journal: J Clin Invest
Title: SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
Volume: 128
Issue: 1
Pages: 381-386
•
•
•
•
•
Publication
27728805 | J:236713
First Author: Dardenne E
Year: 2016
Journal: Cancer Cell
Title: N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
Volume: 30
Issue: 4
Pages: 563-577
•
•
•
•
•
Publication
28870994 | J:301844
First Author: Pascal LE
Year: 2017
Journal: J Endocrinol
Title: Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Volume: 235
Issue: 2
Pages: 123-136
•
•
•
•
•
Publication
31277777 | J:309459
First Author: Shinde D
Year: 2019
Journal: Eur Urol Oncol
Title: Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer.
Volume: 2
Issue: 4
Pages: 415-424
•
•
•
•
•
Publication
35393570 | J:349055
First Author: Fang L
Year: 2022
Journal: Cancer Gene Ther
Title: TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.
Volume: 29
Issue: 10
Pages: 1463-1476
•
•
•
•
•
Publication
30333152 | J:271158
First Author: Elfandy H
Year: 2019
Journal: Mol Cancer Res
Title: Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Volume: 17
Issue: 2
Pages: 446-456
•
•
•
•
•
Publication
19176516 | J:261276
First Author: Nardella C
Year: 2009
Journal: Sci Signal
Title: Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Volume: 2
Issue: 55
Pages: ra2
•
•
•
•
•
Publication
28274958 | J:243131
First Author: Patnaik A
Year: 2017
Journal: Cancer Discov
Title: Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.
Volume: 7
Issue: 7
Pages: 750-765
•
•
•
•
•
Publication
31674011 | J:285566
First Author: Wegner KA
Year: 2020
Journal: J Pathol
Title: Prostate epithelial-specific expression of activated PI3K drives stromal collagen production and accumulation.
Volume: 250
Issue: 2
Pages: 231-242
•
•
•
•
•
Publication
29335545 | J:260988
First Author: Chen M
Year: 2018
Journal: Nat Genet
Title: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Volume: 50
Issue: 2
Pages: 206-218
•
•
•
•
•
Publication
28807943 | J:245648
First Author: Bainor AJ
Year: 2017
Journal: Cancer Res
Title: Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
Volume: 77
Issue: 19
Pages: 5339-5348
•
•
•
•
•
Publication
29187400 | J:256311
First Author: Martín-Martín N
Year: 2018
Journal: Cancer Res
Title: PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.
Volume: 78
Issue: 2
Pages: 399-409
•
•
•
•
•
Publication
25189881 | J:312333
First Author: Wiles WG 4th
Year: 2014
Journal: In Vivo
Title: Mutation of murine Sox4 untranslated regions results in partially penetrant perinatal lethality.
Volume: 28
Issue: 5
Pages: 709-18
•
•
•
•
•
Publication
25712341 | J:220160
First Author: Liu R
Year: 2015
Journal: Cancer Res
Title: FOXP3-miR-146-NF-κB Axis and Therapy for Precancerous Lesions in Prostate.
Volume: 75
Issue: 8
Pages: 1714-24
•
•
•
•
•
Publication
31229879 | J:288972
First Author: Pascal LE
Year: 2019
Journal: Neoplasia
Title: Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Volume: 21
Issue: 8
Pages: 752-764
•
•
•
•
•
Publication
20517984 | J:168861
First Author: Zhang L
Year: 2010
Journal: Stem Cells
Title: Dicer ablation impairs prostate stem cell activity and causes prostate atrophy.
Volume: 28
Issue: 7
Pages: 1260-9
•
•
•
•
•
Publication
33500545 | J:306413
First Author: Albino D
Year: 2021
Journal: Commun Biol
Title: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer.
Volume: 4
Issue: 1
Pages: 119
•
•
•
•
•
Publication
29950727 | J:265287
First Author: Calcinotto A
Year: 2018
Journal: Nature
Title: IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Volume: 559
Issue: 7714
Pages: 363-369
•
•
•
•
•
Publication
23552839 | J:232842
 
First Author: Xiong X
Year: 2012
Journal: Oncogenesis
Title: Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice.
Volume: 1
Pages: e26
•
•
•
•
•
Publication
29121168 | J:257858
First Author: Wang H
Year: 2018
Journal: Carcinogenesis
Title: δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.
Volume: 39
Issue: 2
Pages: 158-169
•
•
•
•
•
Publication
29142193 | J:338791
First Author: Wozniak DJ
Year: 2017
Journal: Nat Commun
Title: PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Volume: 8
Issue: 1
Pages: 1508
•
•
•
•
•
Publication
24934715 | J:314602
First Author: Sun X
Year: 2014
Journal: Neoplasia
Title: Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.
Volume: 16
Issue: 5
Pages: 377-89
•
•
•
•
•
Publication
32219437 | J:289861
 
First Author: Hermanova I
Year: 2020
Journal: J Exp Med
Title: Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
Volume: 217
Issue: 6
•
•
•
•
•
Publication
34230470 | J:307918
First Author: Zoma M
Year: 2021
Journal: Nat Commun
Title: EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Volume: 12
Issue: 1
Pages: 4147
•
•
•
•
•
Publication
25099011 | J:216207
First Author: Xie Y
Year: 2014
Journal: Mol Endocrinol
Title: Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.
Volume: 28
Issue: 10
Pages: 1629-39
•
•
•
•
•
Publication
29056325 | J:251968
First Author: Malek M
Year: 2017
Journal: Mol Cell
Title: PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K.
Volume: 68
Issue: 3
Pages: 566-580.e10
•
•
•
•
•
Publication
18594509 | J:138565
First Author: Jia S
Year: 2008
Journal: Nature
Title: Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
Volume: 454
Issue: 7205
Pages: 776-9
•
•
•
•
•
Publication
34610416 | J:314038
 
First Author: Kanagasabai T
Year: 2021
Journal: Cancer Lett
Title: MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Volume: 525
Pages: 46-54
•
•
•
•
•
Publication
32312982 | J:289154
First Author: Cheng J
Year: 2020
Journal: Nat Commun
Title: TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism.
Volume: 11
Issue: 1
Pages: 1880
•
•
•
•
•
Publication
19281769 | J:147066
First Author: Couto SS
Year: 2009
Journal: Differentiation
Title: Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
Volume: 77
Issue: 1
Pages: 103-11
•
•
•
•
•
Publication
39609420 | J:359314
First Author: Portale F
Year: 2024
Journal: Nat Commun
Title: C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer.
Volume: 15
Issue: 1
Pages: 10343
•
•
•
•
•
Publication
22960283 | J:190538
First Author: Simons BW
Year: 2012
Journal: Dev Biol
Title: Wnt signaling though beta-catenin is required for prostate lineage specification.
Volume: 371
Issue: 2
Pages: 246-55
•
•
•
•
•
Publication
38336745 | J:345284
First Author: Kim WK
Year: 2024
Journal: Nat Commun
Title: Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation.
Volume: 15
Issue: 1
Pages: 1231
•
•
•
•
•
Publication
24229711 | J:206734
First Author: Zhao H
Year: 2013
Journal: Cancer Cell
Title: Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors.
Volume: 24
Issue: 5
Pages: 645-59
•
•
•
•
•
Publication
35013322 | J:330403
First Author: Qi Z
Year: 2022
Journal: Nat Commun
Title: Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment.
Volume: 13
Issue: 1
Pages: 182
•
•
•
•
•
Publication
26198641 | J:224447
 
First Author: Pencik J
Year: 2015
Journal: Nat Commun
Title: STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Volume: 6
Pages: 7736
•
•
•
•
•
Publication
19117991 | J:143034
First Author: Pearson HB
Year: 2009
Journal: Cancer Res
Title: K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
Volume: 69
Issue: 1
Pages: 94-101
•
•
•
•
•
Publication
14691534 | J:86212
First Author: Trotman LC
Year: 2003
Journal: PLoS Biol
Title: Pten dose dictates cancer progression in the prostate.
Volume: 1
Issue: 3
Pages: E59
•
•
•
•
•
Publication
29134654 | J:250840
First Author: Jefferies MT
Year: 2017
Journal: J Pathol
Title: PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Volume: 243
Issue: 4
Pages: 442-456
•
•
•
•
•
Publication
31819003 | J:284956
First Author: Aldahl J
Year: 2020
Journal: J Biol Chem
Title: Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Volume: 295
Issue: 2
Pages: 631-644
•
•
•
•
•
Publication
21151173 | J:173730
First Author: Yu X
Year: 2011
Journal: Oncogene
Title: Wnt/β-catenin activation promotes prostate tumor progression in a mouse model.
Volume: 30
Issue: 16
Pages: 1868-79
•
•
•
•
•
Publication
11231059 | J:68167
First Author: Wu X
Year: 2001
Journal: Mech Dev
Title: Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.
Volume: 101
Issue: 1-2
Pages: 61-9
•
•
•
•
•
Publication
17553900 | J:122263
First Author: Zhou Z
Year: 2007
Journal: Cancer Res
Title: Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
Volume: 67
Issue: 12
Pages: 5683-90
•
•
•
•
•
Publication
23630575 | J:200568
First Author: Cheng CY
Year: 2013
Journal: PLoS One
Title: Detection and organ-specific ablation of neuroendocrine cells by synaptophysin locus-based BAC cassette in transgenic mice.
Volume: 8
Issue: 4
Pages: e60905
•
•
•
•
•
Publication
29530483 | J:271107
 
First Author: Lu H
Year: 2018
Journal: Matrix Biol
Title: Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.
Volume: 70
Pages: 20-35
•
•
•
•
•
Publication
24910389 | J:316436
First Author: Xie Y
Year: 2014
Journal: Mol Oncol
Title: Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.
Volume: 8
Issue: 7
Pages: 1355-64
•
•
•
•
•
Publication
27356744 | J:264783
First Author: Xie Y
Year: 2016
Journal: Oncotarget
Title: MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.
Volume: 7
Issue: 30
Pages: 47609-47619
•
•
•
•
•
Publication
29185453 | J:255776
First Author: Xie Y
Year: 2017
Journal: Sci Rep
Title: Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots.
Volume: 7
Issue: 1
Pages: 16577
•
•
•
•
•
Publication
20237562 | J:158121
First Author: Lin HK
Year: 2010
Journal: Nature
Title: Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Volume: 464
Issue: 7287
Pages: 374-9
•
•
•
•
•
Publication
20103652 | J:156856
First Author: Thomsen MK
Year: 2010
Journal: Cancer Res
Title: SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
Volume: 70
Issue: 3
Pages: 979-87
•
•
•
•
•
Publication
22341455 | J:186105
First Author: Ding Z
Year: 2012
Journal: Cell
Title: Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.
Volume: 148
Issue: 5
Pages: 896-907
•
•
•
•
•
Publication
21703421 | J:173998
First Author: Martin P
Year: 2011
Journal: Am J Pathol
Title: Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
Volume: 179
Issue: 1
Pages: 422-35
•
•
•
•
•
Publication
35653190 | J:332383
 
First Author: Kumar R
Year: 2022
Journal: J Clin Invest
Title: A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60.
Volume: 132
Issue: 13
•
•
•
•
•
Publication
30467381 | J:349042
First Author: Weng CC
Year: 2019
Journal: Oncogene
Title: Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.
Volume: 38
Issue: 12
Pages: 2005-2019
•
•
•
•
•
Publication
25296641 | J:217182
 
First Author: Chinnam M
Year: 2014
Journal: J Natl Cancer Inst
Title: The Thoc1 ribonucleoprotein and prostate cancer progression.
Volume: 106
Issue: 11
•
•
•
•
•
Publication
29437778 | J:262260
     
First Author: Jurmeister S
Year: 2018
Journal: EMBO Mol Med
Title: Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
•
•
•
•
•
Publication
27669461 | J:239553
First Author: Kim SM
Year: 2016
Journal: J Clin Invest
Title: Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.
Volume: 126
Issue: 11
Pages: 4088-4102
•
•
•
•
•
Publication
38016952 | J:360598
First Author: Ji Y
Year: 2023
Journal: Nat Commun
Title: The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Volume: 14
Issue: 1
Pages: 7794
•
•
•
•
•
Publication
37875657 | J:344826
First Author: Miller KA
Year: 2024
Journal: Oncogene
Title: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Volume: 43
Issue: 1
Pages: 22-34
•
•
•
•
•
Publication
34099734 | J:307910
First Author: Brady NJ
Year: 2021
Journal: Nat Commun
Title: Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
Volume: 12
Issue: 1
Pages: 3372
•
•
•
•
•
Publication
25818291 | J:228170
First Author: Mak P
Year: 2015
Journal: Cell Rep
Title: Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.
Volume: 10
Issue: 12
Pages: 1982-91
•
•
•
•
•
Publication
24691769 | J:317509
First Author: Zhang Q
Year: 2014
Journal: Prostate
Title: Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.
Volume: 74
Issue: 8
Pages: 869-79
•
•
•
•
•
Publication
25455686 | J:217813
First Author: Burcham GN
Year: 2014
Journal: Am J Pathol
Title: Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.
Volume: 184
Issue: 12
Pages: 3176-91
•
•
•
•
•
Publication
29720449 | J:261540
 
First Author: Nguyen HG
Year: 2018
Journal: Sci Transl Med
Title: Development of a stress response therapy targeting aggressive prostate cancer.
Volume: 10
Issue: 439
•
•
•
•
•
Publication
38781024 | J:351316
 
First Author: Zhang B
Year: 2024
Journal: J Clin Invest
Title: Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.
Volume: 134
Issue: 14
•
•
•
•
•
Publication
35675421 | J:326992
First Author: Patel R
Year: 2022
Journal: Cancer Res
Title: Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Volume: 82
Issue: 14
Pages: 2565-2575
•
•
•
•
•
Publication
39560993 | J:360985
 
First Author: Morel KL
Year: 2024
Journal: J Clin Invest
Title: Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
Volume: 135
Issue: 2
•
•
•
•
•
Publication
23308230 | J:195810
First Author: Kwak MK
Year: 2013
Journal: PLoS One
Title: Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Volume: 8
Issue: 1
Pages: e53476
•
•
•
•
•
Publication
28323888 | J:247150
First Author: Yu EJ
Year: 2017
Journal: PLoS One
Title: LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
Volume: 12
Issue: 3
Pages: e0174357
•
•
•
•
•
Publication
28515147 | J:242569
First Author: Loveridge CJ
Year: 2017
Journal: Cancer Res
Title: Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.
Volume: 77
Issue: 12
Pages: 3158-3168
•
•
•
•
•
Publication
25425963 | J:243532
First Author: Xing C
Year: 2014
Journal: Neoplasia
Title: Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Volume: 16
Issue: 11
Pages: 883-99
•
•
•
•
•
Publication
23201680 | J:194187
First Author: Qin J
Year: 2013
Journal: Nature
Title: COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
Volume: 493
Issue: 7431
Pages: 236-40
•
•
•
•
•
Publication
29844571 | J:277573
First Author: Liao CP
Year: 2018
Journal: Oncogene
Title: Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Volume: 37
Issue: 38
Pages: 5175-5190
•
•
•
•
•
Publication
24480624 | J:208327
First Author: Zhong J
Year: 2014
Journal: Cancer Res
Title: p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.
Volume: 74
Issue: 6
Pages: 1870-1880
•
•
•
•
•
Publication
31366581 | J:279767
 
First Author: Liu Y
Year: 2019
Journal: Sci Transl Med
Title: The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.
Volume: 11
Issue: 503
•
•
•
•
•
Publication
24464914 | J:208332
First Author: Geary LA
Year: 2014
Journal: Mol Cancer Res
Title: CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features.
Volume: 12
Issue: 4
Pages: 607-21
•
•
•
•
•
Publication
28319045 | J:243606
First Author: Li N
Year: 2017
Journal: J Clin Invest
Title: AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Volume: 127
Issue: 4
Pages: 1284-1302
•
•
•
•
•
Publication
23258246 | J:194362
First Author: Jia S
Year: 2013
Journal: Cancer Discov
Title: Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention.
Volume: 3
Issue: 1
Pages: 44-51
•
•
•
•
•
Publication
23434594 | J:196384
First Author: Patel R
Year: 2013
Journal: J Clin Invest
Title: Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Volume: 123
Issue: 3
Pages: 1157-75
•
•
•
•
•
Publication
26577921 | J:301636
First Author: Hsieh AC
Year: 2015
Journal: Sci Signal
Title: Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors.
Volume: 8
Issue: 403
Pages: ra116
•
•
•
•
•
Publication
16489020 | J:106650
First Author: Zhong C
Year: 2006
Journal: Cancer Res
Title: Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Volume: 66
Issue: 4
Pages: 2188-94
•
•
•
•
•
Publication
16424021 | J:106566
First Author: Khodavirdi AC
Year: 2006
Journal: Cancer Res
Title: Increased expression of osteopontin contributes to the progression of prostate cancer.
Volume: 66
Issue: 2
Pages: 883-8
•
•
•
•
•
Publication
25948589 | J:222960
First Author: Ruscetti M
Year: 2015
Journal: Cancer Res
Title: Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.
Volume: 75
Issue: 13
Pages: 2749-59
•
•
•
•
•
Publication
26233892 | J:316240
First Author: Sun X
Year: 2015
Journal: J Genet Genomics
Title: Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis.
Volume: 42
Issue: 7
Pages: 373-82
•
•
•
•
•
Publication
36242915 | J:330340
 
First Author: Lapierre JA
Year: 2022
Journal: Biochem Biophys Res Commun
Title: Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression.
Volume: 634
Pages: 100-107
•
•
•
•
•
Publication
29228234 | J:318882
First Author: Zhao W
Year: 2018
Journal: J Mol Cell Biol
Title: Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer.
Volume: 10
Issue: 4
Pages: 316-330
•
•
•
•
•
Publication
27941799 | J:243234
 
First Author: Revandkar A
Year: 2016
Journal: Nat Commun
Title: Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence.
Volume: 7
Pages: 13719
•
•
•
•
•
Publication
30827887 | J:273246
First Author: Reina-Campos M
Year: 2019
Journal: Cancer Cell
Title: Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.
Volume: 35
Issue: 3
Pages: 385-400.e9
•
•
•
•
•
Publication
30774773 | J:298067
First Author: Wang Y
Year: 2019
Journal: Oncotarget
Title: Prostate-specific loss of UXT promotes cancer progression.
Volume: 10
Issue: 7
Pages: 707-716
•
•
•
•
•
Publication
29523594 | J:262273
 
First Author: Yan Y
Year: 2018
Journal: EMBO Mol Med
Title: Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
Volume: 10
Issue: 4
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom